It was late April when the CDC added impaired taste and/or smell to its list of COVID-19 symptoms. Thanks to AI and natural language processing (NLP), researchers at the Medical University of South Carolina had beaten the federal agency to the punch.

Telemedicine is gaining popularity all over the world, but it makes more sense for some specialties than others.

AI enthusiasts have varying aims and incentives for pushing the technology into healthcare, but many parrot a common set of justifications. Do any of these sound familiar?

Researchers have demonstrated a way to visually explore small-molecule inhibitors that, according to algorithmic suggestions, show potential for targeting COVID-19’s main proteins.

Healthcare AI startups are asserting AI’s fitness for the fight against COVID-19. How’s that working from the perspective of healthcare providers?

After seeing telehealth visits skyrocket 3,700% in April over March—most of them COVID-related—UPMC is touting its use of AI to help patients retain and apply doctors’ guidance offered during virtual visits.

L. Theodore Lawrence Jr., MD, who fought in World War II and went on to treat veterans as a cardiologist, died May 5 due to COVID-19 complications.

CMS has finalized a rule to implement a series of proposals issued earlier this year impacting Medicare Advantage plans and Medicare Part D plan sponsors. The rules were rushed into effect to get them out before the contract year 2021 bid deadline in June.